Boston (1)

Acute Lymphocytic Leukemia (1)

Acute Myeloid Leukemia (1)

Hodgkins Disease (1)

Myelodysplastic Syndrome (1)

Relapsed Refractory Multiple Myeloma (1)

Relapsed/Refractory Chronic Lymphocytic Leukemia (1)

Relapsed/Refractory Non Hodgkin's Lymphoma (1)

Active, not recruiting (1)

phase 1 (1)

Beth Israel Deaconess Medical Center (1)

Genzyme, a Sanofi Company (1)

antithymocyte globulin (1)

clofarabine (1)

drug (1)

Other (1)

Interventional (1)

hodgkins disease

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Jan 25, 2022